ストックスクリーナーアプリを入手
71.86
1.03%
-0.8116
前日終値:
$72.67
開ける：
$73.12
24時間の取引高:
271.93K
Relative Volume:
0.17
時価総額：
$13.00B
収益：
$342.96M
当期純損益:
$-864.29M
株価収益率:
-13.64
EPS:
-5.27
ネットキャッシュフロー:
$-636.03M
1週間 パフォーマンス:
+0.93%
1か月 パフォーマンス:
-0.49%
6か月 パフォーマンス:
+193.21%
1年 パフォーマンス:
+195.14%
1日の値動き範囲:
$70.94
$73.12
1週間の範囲:
$64.86
$73.95
52週間の値動き範囲:
$21.92
$80.53
Insmed Inc Stock (INSM) Company Profile
INSM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| INSM | 71.89 | 13.00B | 342.96M | -864.29M | -636.03M | -5.27 |
| VRTX | 448.10 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.52 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.04 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.65 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.86 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-07-26 | 開始されました | Guggenheim | Buy |
| 2022-12-09 | 開始されました | Mizuho | Buy |
| 2022-12-07 | 開始されました | Barclays | Overweight |
| 2022-11-18 | 開始されました | BofA Securities | Buy |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2021-12-06 | 開始されました | JP Morgan | Overweight |
| 2021-10-19 | 再開されました | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-12-17 | 開始されました | Berenberg | Buy |
| 2020-10-12 | 再開されました | Stifel | Buy |
| 2019-09-03 | 開始されました | Goldman | Buy |
| 2019-04-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-15 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | アップグレード | Goldman | Neutral → Buy |
| 2019-01-02 | 開始されました | Canaccord Genuity | Buy |
| 2018-08-06 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 開始されました | Goldman | Neutral |
| 2018-04-23 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 開始されました | Morgan Stanley | Overweight |
| 2018-01-18 | 開始されました | Credit Suisse | Neutral |
| 2017-09-05 | 繰り返されました | Evercore ISI | Outperform |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-07-11 | 開始されました | Robert W. Baird | Outperform |
| 2016-03-15 | 開始されました | Stifel | Buy |
| 2015-11-09 | ダウングレード | UBS | Buy → Neutral |
| 2015-10-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-06-09 | 開始されました | Citigroup | Neutral |
| 2014-03-26 | 繰り返されました | HC Wainwright | Buy |
すべてを表示
Insmed Inc (INSM) 最新ニュース
Insmed Incorporated (NASDAQ:INSM) Stock Holdings Lifted by Jennison Associates LLC - MarketBeat
Insmed (NASDAQ:INSM) Shares Gap UpWhat's Next? - MarketBeat
Energizer, C3.ai, Insmed And Other Big Stocks Moving Higher On Tuesday - Benzinga
Insmed gains after ending $500M sales pact with Leerink - MSN
Insmed stock gains as $500M sales pact ends (INSM:NASDAQ) - Seeking Alpha
Insmed Incorporated (NASDAQ:INSM) is First Turn Management LLC's 3rd Largest Position - MarketBeat
Oppenheimer Asset Management Inc. Grows Stake in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed's Options: A Look at What the Big Money is Thinking - Benzinga
Analysts Set Insmed Incorporated (NASDAQ:INSM) Price Target at $83.07 - MarketBeat
Victory Capital Management Inc. Buys 308,819 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
WCM Investment Management LLC Purchases 54,806 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Notable Monday Option Activity: INSM, MARA, ALGM - Nasdaq
Insmed stock target reduced, keeps Outperform on Q3 report By Investing.com - Investing.com Canada
TimesSquare Capital Management LLC Invests $35.32 Million in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Principal Financial Group Inc. Acquires 214,130 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Benzinga
Fiera Capital Corp Sells 13,112 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Van ECK Associates Corp Invests $9.14 Million in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Citizentribune
Insmed Issues $4.6M in Stock Options to New Hires at $68.32 Share Price | INSM Stock News - StockTitan
Insmed To Present at November 2024 Investor Conferences - Marketscreener.com
Insmed (INSM) Set for Major Healthcare Conference Circuit: 4 Key Investor Events in November | INSM Stock News - StockTitan
17,682 Shares in Insmed Incorporated (NASDAQ:INSM) Acquired by Harbor Capital Advisors Inc. - MarketBeat
Insmed's SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Canada
Insmed's SWOT analysis: rare disease biotech stock poised for growth - Investing.com
New York State Common Retirement Fund Sells 29,520 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
INSMInsmed, Inc. Latest Stock News & Market Updates - StockTitan
Insmed (INSM) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Emerald Advisers LLC Buys 49,540 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates - MSN
Insmed (NASDAQ:INSM) Announces Earnings Results - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Q3 2024 Earnings Call Transcript - Insider Monkey
Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates - MSN
Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - MSN
Earnings call: Insmed reports strong Q3 growth, eyes brensocatib launch - Investing.com
Earnings call: Insmed reports strong Q3 growth, eyes brensocatib launch By Investing.com - Investing.com UK
Do You Believe in the Growth Potential of Insmed (INSM)? - Yahoo Finance
Truist Financial Reaffirms Buy Rating for Insmed (NASDAQ:INSM) - MarketBeat
Insmed Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Decoding Insmed Inc (INSM): A Strategic SWOT Insight - GuruFocus.com
Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Reven - GuruFocus.com
Insmed: Q3 Earnings Snapshot - The Advocate
Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update - PR Newswire
How to play biotech stocks: Insmed and Wave Life Sciences - Yahoo Finance
Insmed Incorporated (NASDAQ:INSM) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat
Novo Holdings A S Lowers Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Shares Acquired by Creative Planning - MarketBeat
Insmed Inc (INSM) 財務データ
収益
当期純利益
現金流量
EPS
Insmed Inc (INSM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Smith Michael Alexander | Chief Legal Officer |
Sep 13 '24 |
Sale |
74.35 |
27,871 |
2,072,223 |
67,856 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 13 '24 |
Option Exercise |
34.03 |
26,969 |
917,755 |
133,103 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 16 '24 |
Option Exercise |
34.03 |
13,436 |
457,227 |
119,570 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 12 '24 |
Option Exercise |
34.03 |
635 |
21,609 |
106,769 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 13 '24 |
Sale |
74.90 |
26,969 |
2,019,978 |
106,134 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 16 '24 |
Sale |
74.92 |
13,436 |
1,006,625 |
106,134 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 12 '24 |
Sale |
74.92 |
635 |
47,574 |
106,134 |
0.42%
0.16%
大文字化:
|
ボリューム (24 時間):